StockRunway.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
New York, NY -- (SBWIRE) -- 01/21/2014 -- StockRunway.com issues special report on: Trina Solar Limited (ADR)(NYSE:TSL), Hercules Offshore, Inc.(NASDAQ:HERO), ImmunoGen, Inc. (NASDAQ:IMGN), Synta Pharmaceuticals Corp.(NASDAQ:SNTA)
Trina Solar Limited (ADR)(NYSE:TSL) opened its shares at the price of $16.37 for the day. Its closing price was $15.85 after losing -2.76% for the day. The company traded with the total volume of 4.31 million shares, while its average trading volume remained 5.11million shares. The beta of TSL stands at 3.00. Trina Solar Limited, an integrated solar-power products manufacturer, engages in the design, development, manufacture, and sale of photovoltaic (PV) modules worldwide.
Has TSL Found The Bottom and Ready To Move Up? Find Out Here
Hercules Offshore, Inc.(NASDAQ:HERO) percentage change plunged -2.76% to close at $5.64 with the total traded volume of 3.48 million shares, and average volume of 2.66 million. The 52 week range of the stock remained $5.61- $7.96, while its day lowest price was $5.61 and it hit its day highest price at $5.83. Hercules Offshore, Inc., together with its subsidiaries, provides shallow-water drilling and marine services to the oil and natural gas exploration and production industry worldwide.
Has HERO Found The Bottom And Ready To Gain Momentum? Find Out Here
ImmunoGen, Inc. (NASDAQ:IMGN) started its trading session with the price of $16.51 and closed at $16.14 by scoring -2.71%. IMGN’s stocks traded with total volume of 1.69 million shares, while the average trading volume remained 744,312.00 shares. The beta of IMGN stands at 1.88. Day range of the stock was $16.00-$16.72. ImmunoGen, Inc., a biotechnology company, develops targeted anticancer therapeutics. The company develops its products using its targeted antibody payload technology.
Why Should Investors Buy IMGN After the Recent Fall? Just Go Here and Find Out
Synta Pharmaceuticals Corp.(NASDAQ:SNTA) ended its day with the loss of -2.68% and closed at the price of $6.17 after opening at $6.35. Stock traded during its last trading session with the total volume of 1.81 million shares, as compared to its average volume of 1.89 million shares. Synta Pharmaceuticals Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs for treating severe medical conditions, including cancer and chronic inflammatory diseases.
Will SNTA Get Buyers Even After The Recent Rally? Find Out Here
StockRunway.com is an Elite Financial Stock website catering to individual investors, fund managers, investment bankers and equity analysts. Whether you're new to penny stocks or a seasoned veteran, you'll find all the information you will need right here! Our research is a remarkable educational tool for everyone to utilize.
Sign up TODAY and join the vast amount of investors already benefiting from the best free alerts from StockRunway's service today!
This report/release/advertisement is a commercial advertisement and is for general information purposes only. Never invest in any stock featured on our site, Press Releases or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: StockRunway.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever. Read our Full Disclaimer by visiting our website.
Read Our Full Disclaimer at: http://www.stockrunway.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)